Asian Petroprod. (524434)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹24.89 |
| Market Cap | ₹61.12 Cr |
| P/E Ratio | 124.94 |
| ROCE | -16.51% |
| ROE | -4.75% |
| Dividend Yield | 0% |
| Profit Growth | 122.22% |
| Debt/Equity | — |
| Sales Growth | -10.54% |
| 52-Week Range | ₹7 — ₹24.89 |
| Sector | Chemicals & Petrochemicals |
Strengths
- Reported profit growth of 122.22% shows some earnings improvement, albeit from a very low base.
- Piotroski F-Score of 5/9 suggests the company is not in severe financial distress.
- The stock is at its 52-week high of ₹24.89, reflecting strong market interest and momentum.
- Latest quarter sales of ₹9 Cr show the business is still operating and generating revenue.
Concerns
- Negative ROE of -4.75% and ROCE of -16.51% indicate ongoing capital destruction.
- Sales declined 10.54%, and latest quarter net profit is around ₹0 Cr, so earnings power is negligible.
- P/E of 124.94 is unsupportable without real earnings; the high multiple is based on hope, not fundamentals.
- Disclosure is inadequate: book value, debt/equity, and promoter holding are all unavailable.
AI Analysis
This stock fails the first test I insist on: can the company generate a return on capital? The numbers say no. Asian Petroprod earned -4.75% on equity and -16.51% on capital employed in the latest period. When a commodity chemical maker cannot cover its cost of capital, every rupee of sales is a step toward cash exhaustion, not shareholder value. Sales are also falling—down 10.54%—and the latest quarter shows only ₹9 crore of revenue and roughly zero net profit. So why does the market value this at ₹61 crore, or 125 times earnings? The 122% profit growth is a base effect, not evidence of durable strength. The stock has moved from ₹7 to ₹24.89, but price alone is not value. Graham would ask: what is the asset backing? No book value is disclosed. What is the debt position? No debt/equity ratio. What is the promoter's confidence? Not available. That kind of silence is not something I accept. The Piotroski score is 5 out of 9—mild, not compelling. There is no dividend, so my return depends entirely on someone paying more later. That is speculation, not investment. In commodity chemicals, there is no moat unless you are the lowest-cost producer; nothing here tells me Asian Petroprod is. At best this is a turnaround situation, but a turnaround requires visible evidence: margins stabilizing, cash flows turning positive, and management allocating capital sensibly. I see none of that yet. With the price at the top of the 52-week range, the attractive part of the cycle may already be discounted. I would wait on the sidelines until the company proves it can earn a return on capital and grow sales from here. The margin of safety is absent.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer